India may start H1N1 vaccination drive against swine flu in the coming weeks as the bridge clinical trials to ascertain safety of the imported vaccine samples from Sanofi Pasteur is completed and the data submitted for regulatory review.

Otelixizumab, an experimental drug which could offer a potential eight-day course of daily intravenous infusions reducing the amount of insulin they need to inject on a daily basis to control blood sugar in type 1 diabetes patients, is currently in human studies.

Clinical studies of ocrelizumab, an investigational therapy for rheumatoid arthritis by Roche Holding AG and Biogen Idec have been suspended after it caused deaths in some patients in trials.

Synthemax surface, a new synthetic matrix for growing human embryonic stem cells (hESCs)in a scalable manner has been developed by under a collaboration and license agreement between Geron Corporation announced that Corning Incorporated.

TNFerade, an investigational drug to treat cancer which contains the gene for tumour necrosis factor alpha (TNFa), can suppress cancer metastases through activation of the immune system,